“Hemodynamic-GUIDEd Management of Heart Failure”
The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMSa"c HF System in an expanded patient population including heart failure (HF) patients outside of the present indication, but at risk for future HF events or mortality.
Device - CardioMEMSâ„¢ HF System
The CardioMEMSâ„¢ HF System is comprised of a lead-less, battery-less pressure sensor permanently implanted in the PA, which remotely transmits PA pressure measurements from the patient's home to a secure website. Healthcare professionals are able to access these measurements and associated waveforms to remotely guide individualization of medical management for their patients with chronic HF.
Hemodynamic-GUIDEd Management of Heart Failure